STOCK TITAN

InMode to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1-on-1 Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

InMode Ltd. (NASDAQ: INMD), a leader in innovative medical technologies, announced participation in the 7th Annual Needham Virtual Med Tech & Diagnostics Conference on August 16, 2022. Senior management, including Chairman and CEO Moshe Mizrahy and CFO Yair Malca, will engage in one-on-one meetings with investors that day. Interested parties can schedule meetings via their Needham representatives. InMode develops cutting-edge devices using radiofrequency technology for various medical fields, emphasizing minimally invasive surgical solutions.

Positive
  • None.
Negative
  • None.

YOKNEAM, Israel, Aug. 8, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that senior management including Moshe Mizrahy, Chairman and Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the 7th Annual Needham Virtual Med Tech & Diagnostics one-on-one Conference on Tuesday, Aug. 16, 2022.

InMode Ltd. Logo

 

The company will hold one-on-one investor meetings that same day. To schedule a meeting, please contact your Needham representative.

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

 

Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-at-the-7th-annual-needham-virtual-med-tech--diagnostics-1-on-1-conference-301601405.html

SOURCE InMode Ltd.

FAQ

When will InMode participate in the Needham Virtual Med Tech & Diagnostics Conference?

InMode will participate in the Needham Virtual Med Tech & Diagnostics Conference on August 16, 2022.

Who from InMode will speak at the conference?

Chairman and CEO Moshe Mizrahy and CFO Yair Malca will represent InMode at the conference.

How can investors meet with InMode management at the conference?

Investors can schedule one-on-one meetings with InMode management by contacting their Needham representatives.

What technologies does InMode focus on?

InMode specializes in innovative medical technologies using radiofrequency to improve minimally invasive surgical procedures.

Where can I find more information about InMode's investor relations?

More information about InMode's investor relations can be found on their official website.

InMode Ltd. Ordinary Shares

NASDAQ:INMD

INMD Rankings

INMD Latest News

INMD Stock Data

1.43B
84.62M
10.76%
68.74%
9.09%
Medical Devices
Healthcare
Link
United States of America
Yokne'am